SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cytokinetics, Incorporated ( CYTK)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
405 30 0 CYTK
Emcee:  mopgcw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
305I take it that means they've got the rights to these three compounds? So thtuck-4/9/2010
304Cytokinetics Announces Orphan Drug Designation Granted to CK-2017357 for the Tremopgcw-3/11/2010
303Well, the problem is their burn rate, with the high loss estimate and negative CJibacoa-2/16/2010
302Not yet apparently...Thanks for the pointer. Will continue to be patient. takmopgcw-2/16/2010
301Some comments in Forbes may help the stock next week.<g> Message 26319570Jibacoa-2/13/2010
300CS: Cytokinetics Inc. (CYTK) OUTPERFORM [V] M. Aberman CP: US$ 2.99 TP: US$ 9 CAmopgcw-2/4/2010
299SeekingAplha: CC Cytokinetics Inc. (CYTK) Q4 2009 Earnings Call February 03, 201mopgcw-2/4/2010
298Cytokinetics, Incorporated Reports Fourth Quarter and Year End 2009 Financial Remopgcw-2/3/2010
297INTERVIEW-Cytokinetics to test drug for Lou Gehrig's disease * Trial resultmopgcw-2/3/2010
296don't know what these projects will look like, rear-view mirror and ten yearscaram(o)uche-1/16/2010
295Cytokinetics (CYTK) Announces Positive CK-2017357 Phase I Part B 8:33 am ET 01/1mopgcw-1/16/2010
294Thanks for posting the research report. Had been waiting for a long time to addpelion-12/18/2009
293<i> Not many available, so it wouldn't have been a big score.... </mopgcw-12/10/2009
292CS: Cytokinetics Inc. (CYTK) OUTPERFORM [V] M. Aberman CP: US$ 3.13 TP: US$ 8 CAmopgcw-12/10/2009
291Yeah, I barely missed those ~2.20 shares after hours yesterday, by about a hundrscaram(o)uche-12/10/2009
290i was hoping to pick up some of those $2.60 shares this morning, but alas, no dimopgcw-12/10/2009
289Sabry........ sigh......... Not real bright.scaram(o)uche112/10/2009
288Cytokinetics Shares Slump As It Ends Collaboration With Glaxo DOW JONES NEWSWIRmopgcw-12/9/2009
287seekingApha: Cytokinetics' Market Potential 1 comment by: Prohost Biotech Nomopgcw-11/12/2009
28610/29/09 10:54 am ET ... S&P REITERATES BUY OPINION ON SHARES OF CYTOKINETICmopgcw-10/31/2009
285Sell volume relatively low compared to buy side a month ago...implying sell off Trumptown-10/29/2009
284THANKS for the news! Reassuring.biofisher-10/29/2009
283CS: Cytokinetics Inc. (CYTK) OUTPERFORM [V] M. Aberman CP: US$ 4.27 TP: US$ 8 CAmopgcw-10/29/2009
282Needham & Co Downgrades Cytokinetics (CYTK) to Hold; Lack of Near Term Catalmopgcw-10/29/2009
281Any details re the Needham downgrade?biofisher-10/29/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News